Price to Earnings (P/E)
since 2005
Paying user area
Try for free
Boston Scientific Corp. pages available for free this week:
- Common-Size Balance Sheet: Assets
- Analysis of Liquidity Ratios
- Analysis of Short-term (Operating) Activity Ratios
- Analysis of Long-term (Investment) Activity Ratios
- Common Stock Valuation Ratios
- Enterprise Value (EV)
- Capital Asset Pricing Model (CAPM)
- Operating Profit Margin since 2005
- Current Ratio since 2005
- Analysis of Revenues
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Boston Scientific Corp. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Calculation
Boston Scientific Corp., P/E, long-term trends, calculation
| P/E | = | Share price1, 2, 3 | ÷ | Earnings per share1 (EPS) | EPS1 | = | Net income (loss) available to common stockholders1 (in millions) | ÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23, 2023 | = | ÷ | = | ÷ | |||||||
| Feb 23, 2022 | = | ÷ | = | ÷ | |||||||
| Feb 23, 2021 | = | ÷ | = | ÷ | |||||||
| Feb 25, 2020 | = | ÷ | = | ÷ | |||||||
| Feb 19, 2019 | = | ÷ | = | ÷ | |||||||
| Feb 20, 2018 | = | ÷ | = | ÷ | |||||||
| Feb 23, 2017 | = | ÷ | = | ÷ | |||||||
| Feb 24, 2016 | = | ÷ | = | ÷ | |||||||
| Feb 25, 2015 | = | ÷ | = | ÷ | |||||||
| Feb 26, 2014 | = | ÷ | = | ÷ | |||||||
| Feb 22, 2013 | = | ÷ | = | ÷ | |||||||
| Feb 17, 2012 | = | ÷ | = | ÷ | |||||||
| Feb 17, 2011 | = | ÷ | = | ÷ | |||||||
| Feb 26, 2010 | = | ÷ | = | ÷ | |||||||
| Feb 27, 2009 | = | ÷ | = | ÷ | |||||||
| Feb 28, 2008 | = | ÷ | = | ÷ | |||||||
| Mar 1, 2007 | = | ÷ | = | ÷ | |||||||
| Mar 1, 2006 | = | ÷ | = | ÷ |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Boston Scientific Corp. Annual Report.
The analyzed financial data reveals several notable trends in the company’s performance over the period from 2006 to 2023.
- Share Price
- The share price experienced a significant decline from US$24.00 in 2006 to a low point of US$6.09 in 2012. Following this decline, there was a marked recovery and growth trend, with the share price increasing steadily to reach US$47.18 by 2023. This represents an almost eightfold increase from the 2012 low, indicating a strong positive market sentiment and improved valuation in recent years.
- Earnings per Share (EPS)
- The EPS data shows a volatile pattern with several periods of negative earnings, particularly from 2007 through 2011, including a notable low of -3.00 in 2012. After 2012, EPS values fluctuated but generally showed gradual improvement, culminating in positive earnings peaks in 2019 (US$1.21) and 2020 (US$3.37). However, the year 2021 saw a decline to -0.08, followed by a recovery to positive values in 2022 (US$0.69) and 2023 (US$0.45). The variability in EPS highlights intermittent profitability challenges but a tendency towards regaining positive earnings in the last decade.
- Price-to-Earnings (P/E) Ratio
- The P/E ratio data is incomplete but indicates wide fluctuations where available. The initial P/E ratio in 2006 was 31.4, a relatively elevated valuation. During periods of poor or negative earnings, the P/E ratio data are missing or not applicable, reflecting negative or negligible earnings. Significant spikes in P/E are observed in 2017 (96.19) and 2018 (354.7), suggesting that the market price was high relative to very low earnings per share during these years. The P/E ratio moderated to more reasonable levels by 2020 (33.06) and 2021 (11.86), before showing elevated values again in 2022 (63.31) and 2023 (105.44), pointing to either market optimism or earnings volatility impacting valuation multiples in recent years.
Overall, the data reflects a company that endured a challenging financial period between 2007 and 2012, characterized by declining share price and negative earnings. The subsequent years show an improvement in market valuation and a general trend towards profitability, though with considerable fluctuations. Elevated P/E ratios in recent years highlight ongoing market expectations relative to earnings performance, which remains variable.
Comparison to Competitors
Boston Scientific Corp., P/E, long-term trends, comparison to competitors
| Boston Scientific Corp. | Abbott Laboratories | CVS Health Corp. | Elevance Health Inc. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|---|---|
| Feb 23, 2023 | |||||||
| Feb 23, 2022 | |||||||
| Feb 23, 2021 | |||||||
| Feb 25, 2020 | |||||||
| Feb 19, 2019 | |||||||
| Feb 20, 2018 | |||||||
| Feb 23, 2017 | |||||||
| Feb 24, 2016 | |||||||
| Feb 25, 2015 | |||||||
| Feb 26, 2014 | |||||||
| Feb 22, 2013 | |||||||
| Feb 17, 2012 | |||||||
| Feb 17, 2011 | |||||||
| Feb 26, 2010 | |||||||
| Feb 27, 2009 | |||||||
| Feb 28, 2008 | |||||||
| Mar 1, 2007 | |||||||
| Mar 1, 2006 |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Health Care Equipment & Services)
Boston Scientific Corp., P/E, long-term trends, comparison to sector (health care equipment & services)
| Boston Scientific Corp. | Health Care Equipment & Services | |
|---|---|---|
| Feb 23, 2023 | ||
| Feb 23, 2022 | ||
| Feb 23, 2021 | ||
| Feb 25, 2020 | ||
| Feb 19, 2019 | ||
| Feb 20, 2018 | ||
| Feb 23, 2017 | ||
| Feb 24, 2016 | ||
| Feb 25, 2015 | ||
| Feb 26, 2014 | ||
| Feb 22, 2013 | ||
| Feb 17, 2012 | ||
| Feb 17, 2011 | ||
| Feb 26, 2010 | ||
| Feb 27, 2009 | ||
| Feb 28, 2008 | ||
| Mar 1, 2007 | ||
| Mar 1, 2006 |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Boston Scientific Corp., P/E, long-term trends, comparison to industry (health care)
| Boston Scientific Corp. | Health Care | |
|---|---|---|
| Feb 23, 2023 | ||
| Feb 23, 2022 | ||
| Feb 23, 2021 | ||
| Feb 25, 2020 | ||
| Feb 19, 2019 | ||
| Feb 20, 2018 | ||
| Feb 23, 2017 | ||
| Feb 24, 2016 | ||
| Feb 25, 2015 | ||
| Feb 26, 2014 | ||
| Feb 22, 2013 | ||
| Feb 17, 2012 | ||
| Feb 17, 2011 | ||
| Feb 26, 2010 | ||
| Feb 27, 2009 | ||
| Feb 28, 2008 | ||
| Mar 1, 2007 | ||
| Mar 1, 2006 |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).